Structural and functional characterization of a single-chain peptide - MHC molecule that modulates both naive and activated CD8 + T cells

Dibyendu Samanta, Gayatri Mukherjee, Udupi A. Ramagopal, Rodolfo J. Chaparro, Stanley G. Nathenson, Teresa P. DiLorenzo, Steven C. Almo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Peptide - MHC (pMHC) multimers, in addition to being tools for tracking and quantifying antigen-specific T cells, can mediate downstream signaling after T-cell receptor engagement. In the absence of costimulation, this can lead to anergy or apoptosis of cognate T cells, a property that could be exploited in the setting of autoimmune disease. Most studies with class I pMHC multimers used noncovalently linked peptides, which can allow unwanted CD8 + T-cell activation as a result of peptide transfer to cellular MHC molecules. To circumvent this problem, and given the role of self-reactive CD8 + T cells in the development of type 1 diabetes, we designed a single-chain pMHC complex (scK d.IGRP) by using the class I MHC molecule H-2K d and a covalently linked peptide derived from islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP 206-214), a well established autoantigen in NOD mice. X-ray diffraction studies revealed that the peptide is presented in the groove of the MHC molecule in canonical fashion, and it was also demonstrated that scK d.IGRP tetramers bound specifically to cognate CD8 + T cells. Tetramer binding induced death of naive T cells and in vitro- and in vivo-differentiated cytotoxic T lymphocytes, and tetramer-treated cytotoxic T lymphocytes showed a diminished IFN-γ response to antigen stimulation. Tetramer accessibility to disease-relevant T cells in vivo was also demonstrated. Our study suggests the potential of single-chain pMHC tetramers as possible therapeutic agents in autoimmune disease. Their ability to affect the fate of naive and activated CD8 + T cells makes them a potential intervention strategy in early and late stages of disease.

Original languageEnglish (US)
Pages (from-to)13682-13687
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
Issue number33
DOIs
StatePublished - Aug 16 2011

Fingerprint

T-Lymphocytes
Peptides
Cytotoxic T-Lymphocytes
Autoimmune Diseases
Antigens
Glucose-6-Phosphatase
Inbred NOD Mouse
Autoantigens
T-Cell Antigen Receptor
Type 1 Diabetes Mellitus
X-Ray Diffraction
Catalytic Domain
Apoptosis
Proteins

ASJC Scopus subject areas

  • General

Cite this

Structural and functional characterization of a single-chain peptide - MHC molecule that modulates both naive and activated CD8 + T cells. / Samanta, Dibyendu; Mukherjee, Gayatri; Ramagopal, Udupi A.; Chaparro, Rodolfo J.; Nathenson, Stanley G.; DiLorenzo, Teresa P.; Almo, Steven C.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, No. 33, 16.08.2011, p. 13682-13687.

Research output: Contribution to journalArticle

@article{8279fabf806c4112954baf0a8e2f010a,
title = "Structural and functional characterization of a single-chain peptide - MHC molecule that modulates both naive and activated CD8 + T cells",
abstract = "Peptide - MHC (pMHC) multimers, in addition to being tools for tracking and quantifying antigen-specific T cells, can mediate downstream signaling after T-cell receptor engagement. In the absence of costimulation, this can lead to anergy or apoptosis of cognate T cells, a property that could be exploited in the setting of autoimmune disease. Most studies with class I pMHC multimers used noncovalently linked peptides, which can allow unwanted CD8 + T-cell activation as a result of peptide transfer to cellular MHC molecules. To circumvent this problem, and given the role of self-reactive CD8 + T cells in the development of type 1 diabetes, we designed a single-chain pMHC complex (scK d.IGRP) by using the class I MHC molecule H-2K d and a covalently linked peptide derived from islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP 206-214), a well established autoantigen in NOD mice. X-ray diffraction studies revealed that the peptide is presented in the groove of the MHC molecule in canonical fashion, and it was also demonstrated that scK d.IGRP tetramers bound specifically to cognate CD8 + T cells. Tetramer binding induced death of naive T cells and in vitro- and in vivo-differentiated cytotoxic T lymphocytes, and tetramer-treated cytotoxic T lymphocytes showed a diminished IFN-γ response to antigen stimulation. Tetramer accessibility to disease-relevant T cells in vivo was also demonstrated. Our study suggests the potential of single-chain pMHC tetramers as possible therapeutic agents in autoimmune disease. Their ability to affect the fate of naive and activated CD8 + T cells makes them a potential intervention strategy in early and late stages of disease.",
author = "Dibyendu Samanta and Gayatri Mukherjee and Ramagopal, {Udupi A.} and Chaparro, {Rodolfo J.} and Nathenson, {Stanley G.} and DiLorenzo, {Teresa P.} and Almo, {Steven C.}",
year = "2011",
month = "8",
day = "16",
doi = "10.1073/pnas.1110971108",
language = "English (US)",
volume = "108",
pages = "13682--13687",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "33",

}

TY - JOUR

T1 - Structural and functional characterization of a single-chain peptide - MHC molecule that modulates both naive and activated CD8 + T cells

AU - Samanta, Dibyendu

AU - Mukherjee, Gayatri

AU - Ramagopal, Udupi A.

AU - Chaparro, Rodolfo J.

AU - Nathenson, Stanley G.

AU - DiLorenzo, Teresa P.

AU - Almo, Steven C.

PY - 2011/8/16

Y1 - 2011/8/16

N2 - Peptide - MHC (pMHC) multimers, in addition to being tools for tracking and quantifying antigen-specific T cells, can mediate downstream signaling after T-cell receptor engagement. In the absence of costimulation, this can lead to anergy or apoptosis of cognate T cells, a property that could be exploited in the setting of autoimmune disease. Most studies with class I pMHC multimers used noncovalently linked peptides, which can allow unwanted CD8 + T-cell activation as a result of peptide transfer to cellular MHC molecules. To circumvent this problem, and given the role of self-reactive CD8 + T cells in the development of type 1 diabetes, we designed a single-chain pMHC complex (scK d.IGRP) by using the class I MHC molecule H-2K d and a covalently linked peptide derived from islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP 206-214), a well established autoantigen in NOD mice. X-ray diffraction studies revealed that the peptide is presented in the groove of the MHC molecule in canonical fashion, and it was also demonstrated that scK d.IGRP tetramers bound specifically to cognate CD8 + T cells. Tetramer binding induced death of naive T cells and in vitro- and in vivo-differentiated cytotoxic T lymphocytes, and tetramer-treated cytotoxic T lymphocytes showed a diminished IFN-γ response to antigen stimulation. Tetramer accessibility to disease-relevant T cells in vivo was also demonstrated. Our study suggests the potential of single-chain pMHC tetramers as possible therapeutic agents in autoimmune disease. Their ability to affect the fate of naive and activated CD8 + T cells makes them a potential intervention strategy in early and late stages of disease.

AB - Peptide - MHC (pMHC) multimers, in addition to being tools for tracking and quantifying antigen-specific T cells, can mediate downstream signaling after T-cell receptor engagement. In the absence of costimulation, this can lead to anergy or apoptosis of cognate T cells, a property that could be exploited in the setting of autoimmune disease. Most studies with class I pMHC multimers used noncovalently linked peptides, which can allow unwanted CD8 + T-cell activation as a result of peptide transfer to cellular MHC molecules. To circumvent this problem, and given the role of self-reactive CD8 + T cells in the development of type 1 diabetes, we designed a single-chain pMHC complex (scK d.IGRP) by using the class I MHC molecule H-2K d and a covalently linked peptide derived from islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP 206-214), a well established autoantigen in NOD mice. X-ray diffraction studies revealed that the peptide is presented in the groove of the MHC molecule in canonical fashion, and it was also demonstrated that scK d.IGRP tetramers bound specifically to cognate CD8 + T cells. Tetramer binding induced death of naive T cells and in vitro- and in vivo-differentiated cytotoxic T lymphocytes, and tetramer-treated cytotoxic T lymphocytes showed a diminished IFN-γ response to antigen stimulation. Tetramer accessibility to disease-relevant T cells in vivo was also demonstrated. Our study suggests the potential of single-chain pMHC tetramers as possible therapeutic agents in autoimmune disease. Their ability to affect the fate of naive and activated CD8 + T cells makes them a potential intervention strategy in early and late stages of disease.

UR - http://www.scopus.com/inward/record.url?scp=80051992049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051992049&partnerID=8YFLogxK

U2 - 10.1073/pnas.1110971108

DO - 10.1073/pnas.1110971108

M3 - Article

C2 - 21825122

AN - SCOPUS:80051992049

VL - 108

SP - 13682

EP - 13687

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 33

ER -